Sequence heterogeneity in the equi merozoite antigen gene (ema-1) of Theileria equi and development of an ema-1-specific TaqMan MGB assay for the detection of T. equi.
Abstract: Although a quantitative real-time PCR assay (qPCR) assay for the detection of Theileria equi has been developed and evaluated, it is possible that additional, as yet undetected 18S rRNA gene sequence variants may exist. A qPCR assay targeting a different gene, used in conjunction with the T. equi 18S rRNA qPCR assay, could assist in the detection of all T. equi genotypes in field samples. A T. equi ema-1-specific qPCR (Ueti et al., 2003) was tested on 107 South African field samples, 90 of which tested positive for T. equi antibody using the immuno-fluorescent antibody test (IFAT). The qPCR assay performed poorly, as T. equi was detected in only 67 of the 90 IFAT-positive field samples at quantification cycle (C(q)) values ranging from 27 to 39.95. Furthermore, a high C(q) value of 36.18 was obtained from DNA extracted from a South African in vitro-cultured T. equi WL isolate [1.38% parasitized erythrocytes (PE)] when a low C(q) value (indicative of a high T. equi DNA concentration) was expected. Approximately 600 bp of the ema-1 gene from 38 South African samples were sequenced and BLASTN analysis confirmed all sequences to be merozoite surface protein genes, with an identity of 87.1-100% to previously published T. equi ema-1 gene sequences. Alignment of the sequences revealed extensive sequence variations in the target regions of the primers and probes (Ueti et al., 2003), explaining the poor performance of the qPCR assay. Based on these observations, we developed a new TaqMan minor-groove binder (MGB) probe-based qPCR assay, targeting a more conserved region of the ema-1 gene. This assay was shown to be efficient and specific, and the detection limit, defined as the concentration at which 95% of T. equi-positive samples are detected, was determined to be 1.4 x 10(-4)% PE. The two ema-1 assays were compared by testing 41 South African field samples in parallel. The results suggested that the new assay was more sensitive than the original assay, as T. equi was detected in more samples and at lower C(q) values when the new assay was used. Phylogenetic analyses of the 18S rRNA gene sequences and ema-1 amino acid sequences from the same samples showed inconsistencies between the clades, indicating that the T. equi 18S rRNA genetic groups previously identified in South Africa may not represent distinct T. equi lineages. It is possible that the different T. equi ema-1 genotypes could be related to antigenic variability and pathogenicity and may be associated with clinical differences in equine piroplasmosis cases, but this remains to be elucidated.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study conducts a comprehensive examination of sequence heterogeneity in the equi merozoite antigen gene (ema-1) of Theileria equi. It also develops an ema-1-specific TaqMan MGB assay for the detection of T. equi, offering a more accurate and sensitive method for detecting this parasite in equine piroplasmosis cases.
Objective and Methodology
The study’s primary aim was to probe further into the potential existence of undetected 18S rRNA gene sequence variants of Theileria equi, a causative agent of equine piroplasmosis. The researchers wanted to evaluate whether a qPCR assay targeting a different gene could enhance the detection of all T. equi genotypes in field samples.
They tested a T. equi ema-1-specific qPCR on 107 South African field samples, from which 90 tested positive for T. equi antibody with the immuno-fluorescent antibody test (IFAT).
Additionally, the researchers extracted genes from samples and sequenced them. This additional data was processed using BLASTN analysis and alignment for in-depth understanding.
Results and Analysis
The qPCR assay observed performance issues. Out of 90 IFAT-positive field samples, the qPCR assay identified T. equi in only 67 of them.
The researchers found substantial sequence variation in the target regions of the primers and probes, explaining the poor performance of the qPCR assay.
The study revealed an identity of 87.1-100% between sequenced field samples and published T. equi ema-1 gene sequences.
New Assay Development and Evaluation
Based on these observations, the researchers developed a fresh TaqMan minor-groove binder (MGB) probe-based qPCR assay, targeting a more conserved region of the ema-1 gene.
This assay proved itself as efficient and specific. The detection limit for T. equi-positive samples was also identified, establishing the assay’s merits.
When tested with 41 South African field samples in parallel with the prior qPCR assay, the new assay showed higher sensitivity and accuracy.
Interpretations and Further Implications
Additionally, discrepancies were found between the 18S rRNA gene sequences’ phylogenetic analyses and the ema-1 amino acid sequences from the samples. This variance indicated that previously identified T. equi 18S rRNA genetic groups in South Africa might not be distinct T. equi lineages.
The study hypothesized that different T. equi ema-1 genotypes could relate to antigenic variability and pathogenicity, possibly impacting clinical differences in equine piroplasmosis cases. However, this theory needs further exploration and evidence.
Cite This Article
APA
Bhoora R, Quan M, Matjila PT, Zweygarth E, Guthrie AJ, Collins NE.
(2010).
Sequence heterogeneity in the equi merozoite antigen gene (ema-1) of Theileria equi and development of an ema-1-specific TaqMan MGB assay for the detection of T. equi.
Vet Parasitol, 172(1-2), 33-45.
https://doi.org/10.1016/j.vetpar.2010.04.025
Elsawy BSM, Mahmoud MS, Suarez CE, Alzan HF. Impact of Equine and Camel Piroplasmosis in Egypt: How Much Do We Know about the Current Situation?. Pathogens 2023 Nov 5;12(11).